Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study
Publication date: Available online 12 September 2020Source: Arab Journal of GastroenterologyAuthor(s): Eslam Safwat, Manar Salah, Hany Hussein
Source: Arab Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Diarrhoea | Gastroenterology | Irritable Bowel Syndrome | Middle East Health | Study | Xifaxan